585 related articles for article (PubMed ID: 29128164)
1. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
[TBL] [Abstract][Full Text] [Related]
2. Early grey matter changes in structural covariance networks in Huntington's disease.
Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington's disease patients.
Ramirez-Garcia G; Galvez V; Diaz R; Bayliss L; Fernandez-Ruiz J; Campos-Romo A
Eur J Neurosci; 2020 Apr; 51(8):1827-1843. PubMed ID: 31705594
[TBL] [Abstract][Full Text] [Related]
4. Structural brain correlates of dementia in Huntington's disease.
Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
[TBL] [Abstract][Full Text] [Related]
5. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
[TBL] [Abstract][Full Text] [Related]
6. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
[TBL] [Abstract][Full Text] [Related]
7. Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.
Hong Y; O'Donnell LJ; Savadjiev P; Zhang F; Wassermann D; Pasternak O; Johnson H; Paulsen J; Vonsattel JP; Makris N; Westin CF; Rathi Y
Hum Brain Mapp; 2018 Oct; 39(10):3871-3883. PubMed ID: 29797744
[TBL] [Abstract][Full Text] [Related]
8. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
9. Regional specificity of brain atrophy in Huntington's disease.
Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
[TBL] [Abstract][Full Text] [Related]
10. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
Sweidan W; Bao F; Bozorgzad NS; George E
J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
[TBL] [Abstract][Full Text] [Related]
11. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling.
Finegan E; Li Hi Shing S; Chipika RH; Doherty MA; Hengeveld JC; Vajda A; Donaghy C; Pender N; McLaughlin RL; Hardiman O; Bede P
Neuroimage Clin; 2019; 24():102089. PubMed ID: 31795059
[TBL] [Abstract][Full Text] [Related]
12. Extrastriatal degeneration correlates with deficits in the motor domain subscales of the UHDRS.
Galvez V; Ramírez-García G; Hernandez-Castillo CR; Bayliss L; Díaz R; Lopez-Titla MM; Campos-Romo A; Fernandez-Ruiz J
J Neurol Sci; 2018 Feb; 385():22-29. PubMed ID: 29406908
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
14. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
16. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy--results from the TRACK-HD study.
van den Bogaard SJ; Dumas EM; Ferrarini L; Milles J; van Buchem MA; van der Grond J; Roos RA
J Neurol Sci; 2011 Aug; 307(1-2):60-8. PubMed ID: 21624624
[TBL] [Abstract][Full Text] [Related]
17. Automated differentiation of pre-diagnosis Huntington's disease from healthy control individuals based on quadratic discriminant analysis of the basal ganglia: the IMAGE-HD study.
Georgiou-Karistianis N; Gray MA; Domínguez D JF; Dymowski AR; Bohanna I; Johnston LA; Churchyard A; Chua P; Stout JC; Egan GF
Neurobiol Dis; 2013 Mar; 51():82-92. PubMed ID: 23069680
[TBL] [Abstract][Full Text] [Related]
18. Motor network structure and function are associated with motor performance in Huntington's disease.
Müller HP; Gorges M; Grön G; Kassubek J; Landwehrmeyer GB; Süßmuth SD; Wolf RC; Orth M
J Neurol; 2016 Mar; 263(3):539-49. PubMed ID: 26762394
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype.
Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E;
J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498
[TBL] [Abstract][Full Text] [Related]
20. Discriminating chorea-acanthocytosis from Huntington's disease with single-case voxel-based morphometry analysis.
Suzuki F; Sato N; Ota M; Sugiyama A; Shigemoto Y; Morimoto E; Kimura Y; Wakasugi N; Takahashi Y; Futamura A; Kawamura M; Ono K; Nakamura M; Sano A; Watanabe M; Matsuda H; Abe O
J Neurol Sci; 2020 Jan; 408():116545. PubMed ID: 31704285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
